Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Evaluation of the Prognostic Value of FDG PET/CT Parameters for Patients With Surgically Treated Head and Neck Cancer

Evaluation of the Prognostic Value of FDG PET/CT Parameters for Patients With Surgically Treated... Key PointsQuestionIs there an association between parameters of fluorodeoxyglucose F 18–labeled positron emission tomography and computed tomography (FDG-PET/CT) and prognosis among patients with surgically treated head and neck cancer? FindingsThis systematic review of 36 studies that included 3585 unique patients highlights the prognostic value of FDG-PET/CT parameters, especially volumetric parameters, as biomarkers of overall survival, disease-free survival, and distant metastasis among patients with surgically treated head and neck cancer. MeaningThe findings of this review suggest that FDG-PET/CT parameters may be used to identify patients with a higher risk of postsurgical disease progression who could then receive early therapeutic intensification to improve their prognosis without increasing iatrogenic toxic effects; however, further research is required to define a reproducible, reliable FDG-PET/CT–based prognostic model of patients’ mortality and recurrence risks. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Otolaryngology - Head & Neck Surgery American Medical Association

Evaluation of the Prognostic Value of FDG PET/CT Parameters for Patients With Surgically Treated Head and Neck Cancer

Loading next page...
 
/lp/american-medical-association/evaluation-of-the-prognostic-value-of-fdg-pet-ct-parameters-for-GPRh66PVVV
Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
2168-6181
eISSN
2168-619X
DOI
10.1001/jamaoto.2020.0014
Publisher site
See Article on Publisher Site

Abstract

Key PointsQuestionIs there an association between parameters of fluorodeoxyglucose F 18–labeled positron emission tomography and computed tomography (FDG-PET/CT) and prognosis among patients with surgically treated head and neck cancer? FindingsThis systematic review of 36 studies that included 3585 unique patients highlights the prognostic value of FDG-PET/CT parameters, especially volumetric parameters, as biomarkers of overall survival, disease-free survival, and distant metastasis among patients with surgically treated head and neck cancer. MeaningThe findings of this review suggest that FDG-PET/CT parameters may be used to identify patients with a higher risk of postsurgical disease progression who could then receive early therapeutic intensification to improve their prognosis without increasing iatrogenic toxic effects; however, further research is required to define a reproducible, reliable FDG-PET/CT–based prognostic model of patients’ mortality and recurrence risks.

Journal

JAMA Otolaryngology - Head & Neck SurgeryAmerican Medical Association

Published: May 26, 2020

References